Human Monocyte-Derived Suppressor Cell Supernatant Induces Immunoregulatory Effects and Mitigates xenoGvHD
Recently developed cell-based therapies have shown potential for graft-versus-host disease (GvHD) mitigation. Our team previously developed a protocol to generate human monocyte-derived suppressor Cells (HuMoSC), a subpopulation of CD33+ suppressor cells of monocytic origin. CD33+HuMoSC successfully...
Κύριοι συγγραφείς: | , , , , , , , , , , , , , , , , , |
---|---|
Μορφή: | Άρθρο |
Γλώσσα: | English |
Έκδοση: |
Frontiers Media S.A.
2022-03-01
|
Σειρά: | Frontiers in Immunology |
Θέματα: | |
Διαθέσιμο Online: | https://www.frontiersin.org/articles/10.3389/fimmu.2022.827712/full |